Beijing Chest Hospital was established in 1955 and was denominated as the “Central Tuberculosis Institute” originally. The prime title of the hospital was re-designated several times. The rearmost title “Beijing Thoracic Tumor and Tuberculosis Hospital” was re-designated again to the present formal title “Beijing Chest Hospital” recently on June 2007.
The hospital has some affiliated Departments: “Beijing Diagnosis and Treatment Center for Lung Cancer”; “Beijing Diagnosis and Treatment Center on Osteo-articular Tuberculosis ”; “National Base for Clinical Pharmaceutical Trial”; “Clinical Center on Tuberculosis，CDC China”; “WHO Collaborating Center for Research and Training on Tuberculosis”; The hospital is the first batch of conferring unit with award of Doctorate and Master degree on tuberculosis.
The hospital covers 130,000 square meters and its construction area is 60,000 square meters. The general amount of employee are 880; among them 770 are professionals; 100 specialists; 5 outstanding experts; 22 government allowanced experts. There are 20 clinical and technical departments and 10 scientific research departments. The hospital has whole set of equipment including spiral CT, ECT, DR imaging system, line accelerator etc. for tuberculosis and thoracic tumor examination and treatment. It compose an integrated system for diagnosis, medication and basic scientific research for thoracic tumor and tuberculosis. The hospital possess as a thoracic unique Grade 3 level A specialized hospital. A total of 533 inpatient beds are available and will be expanded to 900. Lung cancer and tuberculosis are two highlighted supported disciplines by Beijing Municipality. Beijing Hi-Tech Laboratory—Beijing Molecular Biology Laboratory for Carcinoma— Lung Cancer Branch has been established. A total of 170 awards has been conferred at national, ministerial and municipal level since 1978.
After the setup of the hospital, about 20 pioneer studies on tuberculosis has been contributed to the country, i.e. short course chemotherapy on tuberculosis, vascular operations for the treatment of thoracic tumor, human lung cancer cell line establishment were explored at the first time in China. So far, a total of 50,000 tuberculosis patients has been treated. The hospital completed the integrated national 10th 5-year plan contract program that focused on MDR-TB treatment. It contributed an international leading achievements in MDR-TB, far advanced critical massive tuberculosis and senile tuberculosis . The hospital also contributed a domestic leading positions on the integrated treatment of lung cancer patients, i.e. a total about 40,000 cancer patients has been treated. About 30,000 chest operations had been conducted including 10,000 lung cancer operations. The 5-years’ survival rate of advanced lung cancer reached 34.6%. Comprehensive treatment for lung cancer hold the leading position in China.
Beijing Chest hospital is now facing the new challenges and opportunities. Based on the unique characteristic achievements on tuberculosis and thoracic tumor, the realm of chest fields should been expand widely further and other fields of chest diseases should be also explored. We will focus on advancement of chest specialty, build up first class personnel and premium services brands in the capital city. We will also improve the core competitiveness of the hospital and execute better thoracic specialized functions in Beijing. We have to pay more attention and efforts to build a domestic and international advanced modern thoracic hospital 。